This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
Precision medicine is a rapidly expanding health-care approach that focuses on finding treatments and interventions that work for patients based on their genetic composition rather than their symptoms. One developing trend in precision medicine is the use of artificial intelligence and machine learning to improve the traditional symptom-driven practice of medicine, allowing for early interventions with advanced diagnostics and better, more cost-effective therapies. Stakeholders in the fast-moving era of genomic and molecular medicine are inevitably leaning toward specificity in medical treatment. Pharmaceutical and biotechnology industries are also making strides in drug development pathways that are faster and more predictable, saving time and money. To conclude, while conventional medicine cannot be completely ruled out, it is clear that PM is defining the future of medicine and has a good possibility of supplanting it in the future.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Leveraging blockchain technology, edge computing and federated learning to enhance outcomes in precision medicine
Ingrid Vasiliu Feltes, MEDNAX, United States
Title : The new horizons in the patient- centered care for understanding of the reasons of its health problems – Psychosynthesis approach
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Hegazy theory for interpretation of human parthenogenesis: A new hypothesis
Abdelmonem Awad Hegazy, Zagazig University, Egypt
Title : Precision Oncology and Personalised Medicine: Innovative Technology for the Treatment of Colorectal Cancer
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : The role of CD44v6 as a new immunotherapy target for urothelial cancer
Iris Adriana Maria Lodewijk, Institute of Biomedical Research, Spain